KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Asset Utilization Ratio (2018 - 2026)

Twist Bioscience has reported Asset Utilization Ratio over the past 9 years, most recently at 0.62 for Q1 2026.

  • Quarterly Asset Utilization Ratio rose 7.91% to 0.62 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.62 through Mar 2026, up 7.91% year-over-year, with the annual reading at 0.6 for FY2025, 33.21% up from the prior year.
  • Asset Utilization Ratio was 0.62 for Q1 2026 at Twist Bioscience, up from 0.61 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.62 in Q1 2026 and troughed at 0.18 in Q1 2022.
  • The 5-year median for Asset Utilization Ratio is 0.39 (2024), against an average of 0.4.
  • Year-over-year, Asset Utilization Ratio increased 1.8% in 2022 and then soared 61.77% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.23 in 2022, then skyrocketed by 50.76% to 0.35 in 2023, then skyrocketed by 55.32% to 0.54 in 2024, then increased by 13.3% to 0.61 in 2025, then increased by 1.84% to 0.62 in 2026.
  • Per Business Quant, the three most recent readings for TWST's Asset Utilization Ratio are 0.62 (Q1 2026), 0.61 (Q4 2025), and 0.59 (Q3 2025).